Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. (W8A.DE) Financial Performance & Income Statement Overview
Explore the financials of Walgreens Boots Alliance, Inc. (W8A.DE), including yearly and quarterly data on income, cash flow, and balance sheets.
Walgreens Boots Alliance, Inc. (W8A.DE) Income Statement & Financial Overview
Explore comprehensive income reports for Walgreens Boots Alliance, Inc. W8A.DE, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $38.59B | $39.46B | $37.55B | $36.35B |
| Cost of Revenue | $31.65B | $32.68B | $31.29B | $29.89B |
| Gross Profit | $6.93B | $6.78B | $6.25B | $6.46B |
| Gross Profit Ratio | $0.18 | $0.17 | $0.17 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.89B | $7.01B | $6.95B | $6.39B |
| Operating Expenses | $12.50B | $7.02B | $7.23B | $6.35B |
| Total Costs & Expenses | $40.54B | $39.70B | $38.52B | $36.24B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $129.00M | $122.00M | $131.00M | $113.00M |
| Depreciation & Amortization | $611.00M | $625.00M | $622.00M | $607.00M |
| EBITDA | -$3.51B | -$236.00M | -$245.00M | $971.00M |
| EBITDA Ratio | -$0.09 | -$0.006 | -$0.007 | $0.03 |
| Operating Income | -$1.96B | -$236.00M | -$977.00M | $111.00M |
| Operating Income Ratio | -$0.05 | -$0.006 | -$0.03 | $0.003 |
| Other Income/Expenses (Net) | -$2.29B | -$179.00M | -$21.00M | $140.00M |
| Income Before Tax | -$4.25B | -$415.00M | -$998.00M | $251.00M |
| Income Before Tax Ratio | -$0.11 | -$0.01 | -$0.03 | $0.007 |
| Income Tax Expense | -$212.00M | $66.00M | $2.08B | $20.00M |
| Net Income | -$2.85B | -$265.00M | -$3.005B | $344.00M |
| Net Income Ratio | -$0.07 | -$0.007 | -$0.08 | $0.009 |
| EPS | -$3.30 | -$0.31 | -$3.48 | $0.40 |
| Diluted EPS | -$3.30 | -$0.31 | -$3.48 | $0.40 |
| Weighted Avg Shares Outstanding | $864.10M | $863.80M | $863.70M | $863.10M |
| Weighted Avg Shares Outstanding (Diluted) | $864.10M | $863.80M | $863.70M | $864.30M |
Financial performance has remained strong, with revenue growing from $36.35B in Q3 2024 to $38.59B in Q2 2025. Gross profit continued to perform well, with margins at 18% in the latest quarter. Operating income reached -$1.96B in Q2 2025, holding a steady -5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$3.51B. Net income dropped to -$2.85B, keeping EPS at -$3.30. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan